JUNS
Price:
$1.22
Market Cap:
$42.05M
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer's disease. In addition, it is develo...[Read more]
Industry
Biotechnology
IPO Date
2022-01-18
Stock Exchange
NASDAQ
Ticker
JUNS
According to Jupiter Neurosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.08. This represents a change of -68.25% compared to the average of -16.00 of the last 4 quarters.
The mean historical PE Ratio of Jupiter Neurosciences, Inc. over the last ten years is -42.83. The current -5.08 PE Ratio has changed 1.09% with respect to the historical average. Over the past ten years (40 quarters), JUNS's PE Ratio was at its highest in in the June 2024 quarter at 144.11. The PE Ratio was at its lowest in in the December 2023 quarter at -94.68.
Average
-42.83
Median
-32.70
Minimum
-126.24
Maximum
-11.89
Discovering the peaks and valleys of Jupiter Neurosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 234.58%
Maximum Annual PE Ratio = -11.89
Minimum Annual Increase = -58.98%
Minimum Annual PE Ratio = -126.24
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -126.24 | 234.58% |
| 2023 | -37.73 | 3.64% |
| 2022 | -36.41 | 206.14% |
| 2021 | -11.89 | -58.98% |
| 2020 | -28.99 | 84.13% |
The current PE Ratio of Jupiter Neurosciences, Inc. (JUNS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-66.79
5-year avg
-48.25
10-year avg
-42.83
Jupiter Neurosciences, Inc.’s PE Ratio is less than Skye Bioscience, Inc. (-1.13), less than Serina Therapeutics, Inc. (-2.76), less than Aligos Therapeutics, Inc. (-1.21), greater than ABVC BioPharma, Inc. (-14.15), less than X4 Pharmaceuticals, Inc. (-0.28), less than Kezar Life Sciences, Inc. (-0.65), greater than FibroGen, Inc. (-16.14), less than Genenta Science S.p.A. (-3.44), less than Mersana Therapeutics, Inc. (-1.95), greater than Grace Therapeutics, Inc. (-6.68),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.13 | $38.77M | |
| -2.76 | $37.00M | |
| -1.21 | $62.09M | |
| -14.15 | $36.66M | |
| -0.28 | $43.35M | |
| -0.65 | $45.77M | |
| -16.14 | $33.37M | |
| -3.44 | $35.60M | |
| -1.95 | $137.32M | |
| -6.68 | $46.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jupiter Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jupiter Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Jupiter Neurosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Jupiter Neurosciences, Inc. (JUNS)?
What is the highest PE Ratio for Jupiter Neurosciences, Inc. (JUNS)?
What is the 3-year average PE Ratio for Jupiter Neurosciences, Inc. (JUNS)?
What is the 5-year average PE Ratio for Jupiter Neurosciences, Inc. (JUNS)?
How does the current PE Ratio for Jupiter Neurosciences, Inc. (JUNS) compare to its historical average?